SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

• Jiajia Wu,
• Hong Cai,
• Jia Xia,
• Tianyi Zhang,
• Jiayi Yan,
• Xinhua Shao,
• Amanda Ying Wang,
• Jianxiao Shen,
• Shan Mou

Affiliations

Jiajia Wu

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Hong Cai

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Jia Xia

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Tianyi Zhang

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Jiayi Yan

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Xinhua Shao

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Amanda Ying Wang

Corresponding author at: The Renal and Metabolic Division, George Institute for Global Health, UNSW, Australia.; The Faculty of Medicine and Health Sciences, Macquarie University, NSW Australia, Australia; The Renal and Metabolic Division, George Institute for Global Health, UNSW, Australia; Department of Renal Medicine, Concord Clinical School, The University of Sydney, Australia

Jianxiao Shen

Correspondence to: Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, No.160 PuJian Road, Shanghai 200127, China.; Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Shan Mou

Correspondence to: Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, No.160 PuJian Road, Shanghai 200127, China.; Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China